Physical Activity in Haemodialysis Patients: a Feasibility Study
PA-CKD
A Structured Exercise and Educational Intervention to Increase Physical Activity in Haemodialysis Patients: a Feasibility Study
2 other identifiers
interventional
16
1 country
1
Brief Summary
There is a well established link between physical inactivity and increased mortality in the general population and across many of the more common disease areas including chronic kidney disease (CKD). Patients with CKD have very high levels of morbidity and mortality and are known to have low fitness levels. Randomised controlled trials of exercise have demonstrated the benefits of physical activity for CKD patients. Despite this, physical activity levels remain low and translating these research findings into clinical practice is challenging. This feasibility study aims to assess the feasibility and acceptability of an instructor led structured exercise programme which includes an educational component to engage and increase physical activity levels in haemodialysis patients attending the Oxford University Hospitals Trust haemodialysis unit. Consented participants will fill in a self reported physical activity questionnaire (Human Activity Profile), partake in functional mobility assessments including (Timed-Up and Go) and a chair based exercise programme. At the end of the study, participants, and nursing staff will undertake a semi-structured interview aimed at understanding acceptability of the intervention. The results of this feasibility study will then be used to inform whether a larger trial in haemodialysis patients is feasible. All questionnaires, physical activity interventions and interviews will be undertaken during routine visits to the haemodialysis unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2019
CompletedStudy Start
First participant enrolled
September 23, 2019
CompletedFirst Posted
Study publicly available on registry
September 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 29, 2020
CompletedApril 20, 2022
April 1, 2022
7 months
September 19, 2019
April 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Semi structured interviews and questionnaires targeted to determine participant acceptability of PA intervention and the people delivering it
Interviews with patients and staff
Interviews should last no longer than an hour and will be conducted at month 3 post baseline
Secondary Outcomes (9)
Change is being assessed 3 metre Timed Up and Go
Change from baseline functional mobility at 6 months
Change is being assessed 10 metre walk test
Change from baseline functional mobility at 6 months
Change is being assessed Hand grip strength
Change from baseline arm strength at 6 months
Change is being assessed Wrist worn accelerometery data
Change from baseline of activity at 6 months
Change is being assessed EQ-5D-3L questionnaire
Change from baseline quality of life at 6 months
- +4 more secondary outcomes
Study Arms (1)
Intervention group
EXPERIMENTAL20 participants to receive physical activity educational booklet with instructions on chair based exercises, Instructor-led training on how to perform the chair based exercises, two times a week, over a 6 week period, and motivational interviewing and prompts.
Interventions
Each participant will be given an educational / information booklet. It will include when the right time to engage in Physical Activity. The Chair-based Exercise Program will be the focus of the exercise intervention with written step- by-step instructions with demonstrative image of the exercises. Further details included in this booklet will include, information regarding the benefits of exercise including walking and safety measures in undertaking the exercises. Sports Exercise Instructor led Chair-based Exercise Programme Patients will be given Sports Exercise Instructor led training on how to perform the chair-based exercises, for 6 weeks. This will be delivered during one of the patients' dialysis sessions. The Instructor will deliver a short 10 minute session to patients and deliver safety instruction. Motivational interviewing Motivational interviewing will consist of discussion to encourage the participant without coercion and help them develop goals.
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the trial.
- Male or Female, aged 18 years or above.
- Undergoing regular haemodialysis (2 or 3 times per week) in the Oxford Main and Tarver Dialysis Units
- Is able and willing to comply with all trial requirements.
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial.
You may not qualify if:
- Unable to give consent
- Poor dialysis compliance
- Female participant who is pregnant, lactating or planning pregnancy during the course of the trial.
- Participant with life expectancy of less than 1 month and/or receiving palliative care.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
- Planning to leave Oxford Dialysis units within the study trial
- Absolute contra-indications to PA including:
- Recent significant change in resting ECG suggesting significant ischaemia, recent Myocardial Infarction within 2 days or acute cardiac event
- Unstable angina
- Uncontrolled cardiac arrhythmia causing symptoms or haemodynamic compromise
- Symptomatic severe aortic stenosis
- Uncontrolled symptomatic heart failure
- Acute pulmonary embolus or infarction
- Acute myocarditis or pericarditis
- Third degree heart block
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oxford Brookes Universitylead
- Oxford University Hospitals NHS Trustcollaborator
Study Sites (1)
Oxford University Hospitals NHS FT
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Helen Dawes, PhD
University of Exeter
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Centre for Movement, Occupational and Rehabilitation Sciences
Study Record Dates
First Submitted
September 19, 2019
First Posted
September 25, 2019
Study Start
September 23, 2019
Primary Completion
April 27, 2020
Study Completion
May 29, 2020
Last Updated
April 20, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Time frame: Once all data analysis has taken place and the core findings have been published, they will be archived securely using Arkivum (see above). Dataset preparation will be carried out by individuals with an understanding of data management and basic statistics, with quality control provided by a further individual who is independent of the process. Researchers will be able to apply to access archived data as required.
- Access Criteria
- Once data has been archived in Arkivum, access will be granted to researchers in accordance with NHS and Oxford Brookes policies. Data access requests will be made via an application form detailing the specific requirements and the proposed research and publication plan, which will be reviewed against specific eligibility criteria by data custodians or by an external Independent Review Panel. Decisions about requests will be made promptly (no more than 3 months after receipt of request) and details of all data requests and their outcomes will be made publicly available (data requesters should be informed of this in advance of this). Funds for responsible data sharing will be requested from trial funders as part of initial trial grant applications.
Individual patient data will be shared with other researchers in accordance with NHS Information Governance Policy (NHS Information Sharing Policy v2) and Oxford Brookes data sharing policies (Oxford Brookes IT policies). Plans for data sharing will be included in the data management plan, as well as the trial protocol. A data sharing statement will be included in the consent form and information provided in the patient information leaflet. Data will be pseudonymised wherever possible prior to being shared with other researchers and the information required to "decode" this data will be stored securely elsewhere, in accordance with ICH GCP guidelines. If this is not possible then consent will be obtained from participants and approval sought from the HRA prior to the trial commencing.